skip to main content

S. 2665: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Cosponsors

1 cosponsors (1D) (show)

Committee Assignments

Committee chairs determine whether a bill will move past the committee stage.

Votes

There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 2680 (Related)
Opioid Crisis Response Act of 2018

Ordered Reported
Last Action: Apr 24, 2018

Search for similar bills.

Subject Areas